|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
32,790,000 |
Market
Cap: |
3.28(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$100.05 - $100.05 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Wolff Stefani |
Chief Development Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$1,359,200 |
D/D |
(13,592) |
0 |
|
- |
|
Becker Daniel J. |
Director |
|
2020-09-28 |
4 |
D |
$100.00 |
$66,760,000 |
I/I |
(667,600) |
0 |
|
- |
|
George Simeon |
Director |
|
2020-09-28 |
4 |
D |
$100.00 |
$298,285,500 |
I/I |
(2,982,855) |
0 |
|
- |
|
Hardiman Roy C. |
Chief Business Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$191,600 |
I/I |
(1,916) |
0 |
|
- |
|
Hardiman Roy C. |
Chief Business Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$11,776,100 |
D/D |
(117,761) |
0 |
|
- |
|
Thomas Dolca |
Chief Medical Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$220,700 |
D/D |
(2,207) |
0 |
|
- |
|
Goldstein David |
Chief Scientific Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$3,182,600 |
D/D |
(31,826) |
0 |
|
- |
|
Chai Christopher Y |
Chief Financial Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$330,200 |
I/I |
(3,302) |
0 |
|
- |
|
Chai Christopher Y |
Chief Financial Officer |
|
2020-09-28 |
4 |
D |
$100.00 |
$379,900 |
D/D |
(3,799) |
0 |
|
- |
|
Babler Martin |
President, CEO |
|
2020-09-28 |
4 |
D |
$100.00 |
$5,753,400 |
I/I |
(57,534) |
0 |
|
- |
|
Babler Martin |
President, CEO |
|
2020-09-28 |
4 |
D |
$100.00 |
$102,300 |
D/D |
(1,023) |
0 |
|
- |
|
Wolff Stefani |
Chief Development Officer |
|
2020-09-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,504 |
13,592 |
|
- |
|
Hardiman Roy C. |
Chief Business Officer |
|
2020-09-18 |
4 |
AS |
$99.98 |
$499,918 |
D/D |
(5,000) |
117,761 |
|
-0% |
|
Hardiman Roy C. |
Chief Business Officer |
|
2020-09-18 |
4 |
OE |
$4.72 |
$29,321 |
D/D |
5,000 |
122,761 |
|
- |
|
Thomas Dolca |
Chief Medical Officer |
|
2020-08-18 |
4 |
AS |
$100.00 |
$1,500,000 |
D/D |
(15,000) |
1,826 |
|
0% |
|
Thomas Dolca |
Chief Medical Officer |
|
2020-08-18 |
4 |
OE |
$23.77 |
$356,550 |
D/D |
15,000 |
16,826 |
|
- |
|
Chai Christopher Y |
Chief Financial Officer |
|
2020-08-18 |
4 |
AS |
$99.37 |
$745,240 |
D/D |
(7,500) |
3,539 |
|
0% |
|
Chai Christopher Y |
Chief Financial Officer |
|
2020-08-18 |
4 |
OE |
$3.00 |
$22,483 |
D/D |
7,500 |
11,039 |
|
- |
|
Goldstein David |
Chief Scientific Officer |
|
2020-08-10 |
4 |
AS |
$86.11 |
$531,665 |
D/D |
(6,000) |
31,739 |
|
18% |
|
Goldstein David |
Chief Scientific Officer |
|
2020-08-10 |
4 |
OE |
$3.00 |
$18,632 |
D/D |
6,000 |
37,739 |
|
- |
|
Thomas Dolca |
Chief Medical Officer |
|
2020-07-15 |
4 |
AS |
$80.07 |
$1,201,070 |
D/D |
(15,000) |
1,826 |
|
35% |
|
Thomas Dolca |
Chief Medical Officer |
|
2020-07-15 |
4 |
OE |
$23.77 |
$356,550 |
D/D |
15,000 |
16,826 |
|
- |
|
Colowick Alan |
Director |
|
2020-07-01 |
4 |
AS |
$60.00 |
$450,000 |
D/D |
(7,500) |
0 |
|
71% |
|
Colowick Alan |
Director |
|
2020-07-01 |
4 |
OE |
$4.54 |
$34,065 |
D/D |
7,500 |
7,500 |
|
- |
|
Babler Martin |
President, CEO |
|
2020-06-23 |
4 |
AS |
$60.32 |
$927,889 |
D/D |
(15,000) |
810 |
|
65% |
|
83 Records found
|
|
Page 1 of 4 |
|
|